Dr Eulambius Mlugu holds a PhD in Clinical Pharmacology from Karolinska Institute, Sweden. He works as a lecturer at Muhimbili University of Health and Allied Sciences (MUHAS) in Dar es Salaam, Tanzania. Dr. Mlugu is a WHO/TDR Fellow in Clinical Research Leadership, working with the MARC SE-Africa team collaborating with WWARN on mitigating antimalarial drug resistance in Southeast Africa.
His research interests include malaria, neglected tropical diseases (NTDs) and HIV.
Dr Stephanie van Wyk, a molecular biologist and bioinformatician, has made substantial contributions to public health initiatives through her work on Plasmodium, bacteria, viruses, and fungi, working on disease outbreaks such as malaria, COVID-19, and cholera. Her active involvement in pathogen surveillance has influenced disease mitigation in South Africa and across Africa. Currently a research fellow at the University of Cape Town, she contributes her expertise to the Collaborating Centre for Optimising Antimalarial Therapy (CCOAT) and the Mitigating Antimalarial Resistance Consortium for South and East Africa (MARC SEA) within the Department of Medicine, Division of Clinical Pharmacology. Her focus on malaria epidemiology and genetics is in unravelling the disease's complexities and its treatment.
At CCOAT and MARC SE Africa, Dr. van Wyk's work focuses on malaria epidemiology, mitigation, and genetics. She is deeply involved in science communication, advocating for a broader understanding of pathogen research and its implications for malaria mitigation. She is passionate about her work in data science, particularly in optimising and developing web-based technologies to enhance research and public health responses.
Daniel Yilma is academician and a practicing Internal Medicine physician in Jimma University Medical Center (JUMC). He obtained his PhD in University of Copenhagen. He established clinical trial unit at JUMC and conducts infectious disease research mainly on HIV, Tuberculosis, COVID-19 and malaria . Daniel joined IDDO/WWARN as a WHO/TDR fellow and continued his research as a University of Cape Town (UCT) post-doctoral fellow within the Southern African Centre of IDDO based at the UCT Collaborating Centre for Optimising Antimalarial Therapy. He serves as member of malaria case management team at national level. He works with WWARN and other collaborators to find safe, effective and simplified malaria treatment and diagnostic tools.
Prof Feiko ter Kuile joined WWARN in 2016 as Head of the Malaria in Pregnancy Scientific Group. He is Professor of Clinical Tropical Medicine at the Liverpool School of Tropical Medicine. Prof ter Kuile is a clinical epidemiologist who trained in medicine at the Academic Medical Centre of the University of Amsterdam. He previously worked at the Shoklo Malaria Research Unit (SMRU), the University of Amsterdam, and Mahidol University. Prof ter Kuile then worked with the Centers for Disease Control and Prevention (CDC), first as a research epidemiologist at the CDC field station in Kisumu, Western Kenya for 6 years, then as a senior medical epidemiologist based in Atlanta, GA, USA for 2 years. Since 2007, Prof ter Kuile has led the Malaria in Pregnancy Consortium at the Liverpool School of Tropical Medicine (LSTM), and is currently based at the Centre for Global Health Research, Kenya Medical Research Institute (KEMRI) in Kisumu. His main research interests include the epidemiology of malaria and the evaluation of new interventions for the control of malaria in children and pregnant women.
Prof Ric Price was appointed Head of the Clinical Group in WWARN in 2007. He is an infectious disease physician currently on the staff at the Royal Darwin Hospital, Australia, and an honorary consultant at the John Radcliffe Hospital, Oxford. Ric was appointed Professor of Tropical Medicine at the University of Oxford in 2011 and and Professor of Global Health at the Menzies School of Health Research in Darwin, Australia in 2010. The focus of his academic work is the investigation of multidrug resistant malaria and devising strategies for its containment. He coordinates a field site in Papua, Indonesia investigating the diagnosis and management of drug resistant P. falciparum and P. vivax. This work spans clinical studies, epidemiology, pathophysiology, in vitro studies and molecular biology. Ric also chairs the Vivax Working Group of the Asia Pacific Malaria Elimination Network (APMEN).